Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Versant Ventures II LLC. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Versant Ventures II LLC zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:INGN / Inogen, Inc. | 10% Owner | 55 345 |
| US:EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF | 10% Owner | 4 370 964 |
| US:AKAO / Achaogen, Inc. | 10% Owner | 0 |
| US:KYTH / Kythera Biopharma | 10% Owner | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Versant Ventures II LLC. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Zakupy insidera INGN / Inogen, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera INGN / Inogen, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w EYES / Corgi ETF Trust I - Corgi Data & Surveillance ETF. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Versant Ventures II LLC ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 150 | 55 345 | -5,39 | 23,95 | -75 442 | 1 325 507 | |
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
S - Sale | -4 238 | 58 495 | -6,76 | 24,56 | -104 092 | 1 436 737 | |
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 1 398 | 4 572 | 44,05 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 3 174 | 18,08 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 595 | 14 889 | 60,20 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 9 294 | 2,68 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 595 | 14 889 | 60,20 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 9 294 | 2,68 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 596 | 15 180 | 58,39 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 388 | 9 584 | 4,22 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 594 | 14 789 | 60,84 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 194 | 9 195 | 2,16 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -42 216 | 0 | -100,00 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 42 216 | 42 216 | |||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -389 136 | 2 917 544 | -11,77 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -3 476 | 26 061 | -11,77 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 150 | 55 345 | -5,39 | 23,95 | -75 442 | 1 325 507 | |
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
S - Sale | -4 238 | 58 495 | -6,76 | 24,56 | -104 092 | 1 436 737 | |
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 1 469 | 3 782 | 63,51 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 199 | 13 640 | 61,59 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 5 596 | 5 596 | |||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 2 798 | 3 041 | 1 151,44 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 243 | |||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -42 216 | 0 | -100,00 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 42 216 | 42 216 | |||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -389 136 | 2 917 544 | -11,77 | ||||
| 2015-05-11 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -3 476 | 26 061 | -11,77 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 4 682 | 4 682 | |||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 539 | 52 985 | 49,48 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 916 | 13 196 | 208,32 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 834 | 17 834 | |||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -136 039 | 0 | -100,00 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 13 682 | 3,68 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 136 039 | 136 039 | |||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -778 272 | 1 263 716 | -38,11 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -6 952 | 7 812 | -47,09 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 4 459 | 16 329 | 37,57 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 832 | 56 385 | 46,25 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 832 | 87 719 | 25,52 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 832 | 87 461 | 25,61 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 17 832 | 85 497 | 26,35 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -136 039 | 0 | -100,00 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 972 | 17 301 | 5,95 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 56 871 | 0,86 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 88 205 | 0,55 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 389 | 56 516 | 0,69 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 778 | 54 941 | 1,44 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 136 039 | 136 039 | |||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -778 272 | 1 263 716 | -38,11 | ||||
| 2015-01-08 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -6 952 | 7 812 | -47,09 | ||||
| 2015-01-06 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -7 946 | 0 | -100,00 | 30,98 | -246 159 | ||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 2 084 | 9 785 | 27,06 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 636 | 35 446 | 27,46 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 4 280 | 7,67 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 3 975 | 3 975 | |||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 946 | 7 946 | |||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -60 344 | 0 | -100,00 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 1 126 | 60 344 | 1,90 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 59 218 | 59 218 | |||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -486 420 | 2 041 988 | -19,24 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -4 345 | 14 764 | -22,74 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -9 235 | 31 334 | -22,76 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 607 | 11 870 | 5,39 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 1 986 | 11 263 | 21,41 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 38 553 | 0,80 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 944 | 38 248 | 26,21 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 38 553 | 0,80 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 944 | 38 248 | 26,21 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 244 | 38 295 | 0,64 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 942 | 38 051 | 26,38 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 488 | 36 331 | 1,36 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 7 950 | 35 843 | 28,50 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -60 344 | 0 | -100,00 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 1 126 | 60 344 | 1,90 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | 59 218 | 59 218 | |||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -486 420 | 2 041 988 | -19,24 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -4 345 | 14 764 | -22,74 | ||||
| 2015-01-05 |
|
4/A | INGN |
Inogen Inc
Common Stock |
J - Other | -9 235 | 31 334 | -22,76 | ||||
| 2014-12-29 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -9 785 | 0 | -100,00 | 29,74 | -291 009 | ||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 607 | 11 870 | 5,39 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 1 986 | 11 263 | 21,41 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 38 553 | 0,80 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 38 553 | 0,80 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 944 | 38 248 | 26,21 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 944 | 38 248 | 26,21 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 244 | 38 295 | 0,64 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 942 | 38 051 | 26,38 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 488 | 36 331 | 1,36 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 950 | 35 843 | 28,50 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -60 344 | 0 | -100,00 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 1 126 | 60 344 | 1,90 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 59 218 | 59 218 | |||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -486 420 | 2 041 988 | -19,24 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -4 345 | 14 764 | -22,74 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -9 235 | 31 334 | -22,76 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 2 084 | 9 785 | 27,06 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 636 | 35 446 | 27,46 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 305 | 4 280 | 7,67 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 3 975 | 3 975 | |||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 946 | 7 946 | |||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -60 344 | 0 | -100,00 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 1 126 | 60 344 | 1,90 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 59 218 | 59 218 | |||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -486 420 | 2 041 988 | -19,24 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -4 345 | 14 764 | -22,74 | ||||
| 2014-12-22 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -9 235 | 31 334 | -22,76 | ||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 370 964 | ||||||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
82 949 | ||||||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
39 062 | ||||||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 370 964 | ||||||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
82 949 | ||||||||
| 2014-12-02 | 3/A | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
39 062 | ||||||||
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 500 | 0 | -100,00 | 24,22 | -84 757 | ||
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -7 953 | 0 | -100,00 | 24,79 | -197 158 | ||
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 895 | 3 500 | -52,67 | 24,92 | -97 054 | 87 212 | |
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -7 534 | 7 395 | -50,47 | 24,86 | -187 322 | 183 866 | |
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -5 343 | 40 569 | -11,64 | 24,89 | -132 962 | 1 009 568 | |
| 2014-11-19 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -5 343 | 40 569 | -11,64 | 24,89 | -132 962 | 1 009 568 | |
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
8 862 939 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 574 924 | ||||||||
| 2014-11-18 | 3 | EYES |
SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock |
4 530 037 | ||||||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 928 | 45 912 | -7,88 | 25,06 | -98 446 | 1 150 679 | |
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -5 505 | 49 840 | -9,95 | 25,18 | -138 640 | 1 255 190 | |
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 3 919 | 7 701 | 103,62 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 170 | 27 810 | 103,89 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 929 | 14 929 | |||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 7 953 | 6,51 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 7 467 | 7 467 | |||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -113 112 | 0 | -100,00 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 113 112 | 113 112 | |||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -6 952 | 19 109 | -26,68 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -778 272 | 2 528 408 | -23,54 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 928 | 45 912 | -7,88 | 25,06 | -98 446 | 1 150 679 | |
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -5 505 | 49 840 | -9,95 | 25,18 | -138 624 | 1 255 041 | |
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 972 | 9 277 | 11,70 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 3 733 | 8 305 | 81,65 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 30 304 | 1,63 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 30 304 | 1,63 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 929 | 29 818 | 100,27 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 929 | 29 818 | 100,27 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 929 | 29 818 | 100,27 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 388 | 30 109 | 1,31 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 14 932 | 29 721 | 100,97 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 776 | 27 893 | 2,86 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -113 112 | 0 | -100,00 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 113 112 | 113 112 | |||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -778 272 | 2 528 408 | -23,54 | ||||
| 2014-11-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -6 952 | 19 109 | -26,68 | ||||
| 2014-11-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -5 596 | 0 | -100,00 | 24,48 | -136 979 | ||
| 2014-11-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 041 | 0 | -100,00 | 24,57 | -74 712 | ||
| 2014-11-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -2 992 | 12 188 | -19,71 | 24,42 | -73 065 | 297 632 | |
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 150 | 55 345 | -5,39 | 23,95 | -75 442 | 1 325 507 | |
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -4 238 | 58 495 | -6,76 | 24,56 | -104 092 | 1 436 737 | |
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 1 469 | 3 782 | 63,51 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 199 | 13 640 | 61,59 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 596 | 5 596 | |||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 2 798 | 3 041 | 1 151,44 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 243 | |||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -3 476 | 26 061 | -11,77 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -3 150 | 55 345 | -5,39 | 23,95 | -75 442 | 1 325 507 | |
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -4 238 | 58 495 | -6,76 | 24,56 | -104 092 | 1 436 737 | |
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 1 398 | 4 572 | 44,05 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 3 174 | 18,08 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 595 | 14 889 | 60,20 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 9 294 | 2,68 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 595 | 3 321 569 | 0,17 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 3 315 974 | 0,01 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 596 | 15 180 | 58,39 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 388 | 9 584 | 4,22 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 5 594 | 14 789 | 60,84 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 194 | 9 195 | 2,16 | ||||
| 2014-11-07 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -3 476 | 26 061 | -11,77 | ||||
| 2014-10-28 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -4 647 | 0 | -100,00 | 20,76 | -96 455 | ||
| 2014-10-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -144 | 0 | -100,00 | 20,83 | -2 999 | ||
| 2014-10-14 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -1 756 | 0 | -100,00 | 20,83 | -36 570 | ||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 2 313 | 2 313 | |||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 441 | 8 441 | |||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 4 404 | 4 647 | 1 812,35 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -66 857 | 0 | -100,00 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -525 | 144 | -78,48 | 21,03 | -11 039 | 3 028 | |
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -6 382 | 1 756 | -78,42 | 21,03 | -134 192 | 36 923 | |
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 669 | 669 | |||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 138 | 8 138 | |||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 2 202 | 2 688 | 453,09 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 808 | 9 051 | 3 624,69 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 808 | 9 051 | 3 624,69 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 808 | 3 408 001 | 0,26 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 8 807 | 9 001 | 4 539,69 | ||||
| 2014-10-09 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -66 857 | 0 | -100,00 | ||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 243 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 486 | 486 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 243 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 243 | 243 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 388 | 388 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | 194 | 194 | |||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -389 136 | 3 306 680 | -10,53 | ||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
J - Other | -3 476 | 29 537 | -10,53 | ||||
| 2014-09-12 |
|
4 | INGN |
Inogen Inc
Common Stock |
S - Sale | -7 388 | 62 733 | -10,54 | 23,25 | -171 768 | 1 458 517 | |
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series D Preferred Stock |
C - Conversion | -266 543 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series D Preferred Stock |
C - Conversion | -2 382 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series D Preferred Stock |
C - Conversion | -5 058 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series C Preferred Stock |
C - Conversion | -333 119 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series C Preferred Stock |
C - Conversion | -2 975 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series C Preferred Stock |
C - Conversion | -6 320 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series B Preferred Stock |
C - Conversion | -214 118 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series B Preferred Stock |
C - Conversion | -1 913 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series B Preferred Stock |
C - Conversion | -4 063 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series A Preferred Stock |
C - Conversion | -288 917 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series A Preferred Stock |
C - Conversion | -2 582 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Series A Preferred Stock |
C - Conversion | -5 482 | 0 | -100,00 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 266 543 | 1 246 895 | 27,19 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 333 119 | 980 352 | 51,47 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 284 492 | 647 233 | 78,43 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 331 544 | 362 741 | 1 062,74 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 2 382 | 11 139 | 27,20 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 2 975 | 8 757 | 51,45 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 2 542 | 5 782 | 78,46 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 2 962 | 3 240 | 1 065,47 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 5 058 | 23 118 | 28,01 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 6 320 | 18 060 | 53,83 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 5 399 | 11 740 | 85,14 | ||||
| 2014-03-17 |
|
4 | AKAO |
Achaogen Inc
Common Stock |
C - Conversion | 6 290 | 6 341 | 12 333,33 | ||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 577 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 804 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
62 723 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 577 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 804 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
62 723 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 577 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 804 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
62 723 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 577 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 804 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
62 723 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 577 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
31 804 | ||||||||
| 2014-03-11 | 3 | AKAO |
Achaogen Inc
Common Stock |
62 723 | ||||||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series E Preferred Stock |
C - Conversion | -684 970 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series D Preferred Stock |
C - Conversion | -547 941 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series C Preferred Stock |
C - Conversion | -172 421 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series B Preferred Stock |
C - Conversion | -327 556 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series E Preferred Stock |
C - Conversion | -6 120 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series D Preferred Stock |
C - Conversion | -4 895 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series C Preferred Stock |
C - Conversion | -1 539 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series B Preferred Stock |
C - Conversion | -2 927 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series E Preferred Stock |
C - Conversion | -12 998 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series D Preferred Stock |
C - Conversion | -10 395 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series C Preferred Stock |
C - Conversion | -3 271 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Series B Preferred Stock |
C - Conversion | -6 216 | 0 | -100,00 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Common Stock |
C - Conversion | 3 647 718 | 3 695 816 | 7 583,93 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Common Stock |
C - Conversion | 32 586 | 33 013 | 7 631,38 | ||||
| 2014-02-21 |
|
4 | INGN |
Inogen Inc
Common Stock |
C - Conversion | 69 209 | 70 120 | 7 597,04 | ||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
50 347 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
49 863 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
97 534 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
50 347 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
49 863 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
97 534 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
50 347 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
49 863 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
97 534 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
50 347 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
49 863 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
97 534 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
50 347 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
49 863 | ||||||||
| 2014-02-12 | 3 | INGN |
Inogen Inc
Common Stock |
97 534 | ||||||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
M - Exercise | -2 249 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
J - Other | 2 249 | 2 249 | |||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Preferred Stock |
J - Other | -2 232 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
M - Exercise | -1 059 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
J - Other | 1 059 | 1 059 | |||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Preferred Stock |
J - Other | -1 051 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
M - Exercise | -118 573 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Common Stock |
J - Other | 118 573 | 118 573 | |||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Warrant to Purchase Preferred Stock |
J - Other | -117 650 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series D Preferred Stock |
C - Conversion | -2 766 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series D Preferred Stock |
C - Conversion | -1 303 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series D Preferred Stock |
C - Conversion | -145 796 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series C Preferred Stock |
C - Conversion | -8 614 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series C Preferred Stock |
C - Conversion | -4 055 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series C Preferred Stock |
C - Conversion | -453 925 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series B Preferred Stock |
C - Conversion | -19 658 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series B Preferred Stock |
C - Conversion | -9 258 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series B Preferred Stock |
C - Conversion | -1 035 917 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series A Preferred Stock |
C - Conversion | -10 996 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series A Preferred Stock |
C - Conversion | -5 179 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Series A Preferred Stock |
C - Conversion | -603 612 | 0 | -100,00 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
F - Taxes | -854 | 43 583 | -1,92 | 19,88 | -16 978 | 866 430 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
F - Taxes | -402 | 21 361 | -1,85 | 19,88 | -7 992 | 424 657 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
F - Taxes | -45 010 | 2 414 649 | -1,83 | 19,88 | -894 799 | 48 003 222 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 249 | 44 437 | 5,33 | 7,55 | 16 980 | 335 499 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 059 | 21 763 | 5,11 | 7,55 | 7 995 | 164 311 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 118 573 | 2 459 659 | 5,06 | 7,55 | 895 226 | 18 570 425 | |
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 2 766 | 42 188 | 7,02 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 1 303 | 20 704 | 6,72 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 145 796 | 2 341 086 | 6,64 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 8 614 | 39 422 | 27,96 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 4 055 | 19 401 | 26,42 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 453 925 | 2 195 290 | 26,07 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 19 812 | 30 808 | 180,17 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 9 330 | 15 346 | 155,09 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 1 044 048 | 1 741 365 | 149,72 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 10 996 | 10 996 | |||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 5 179 | 6 016 | 618,76 | ||||
| 2012-10-16 |
|
4 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
C - Conversion | 603 612 | 697 317 | 644,16 | ||||
| 2012-10-10 | 3 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
93 705 | ||||||||
| 2012-10-10 | 3 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
31 388 | ||||||||
| 2012-10-10 | 3 | KYTH |
KYTHERA BIOPHARMACEUTICALS INC
Common Stock |
837 |
